Clinical Trial Update: Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating a doxepin solution to relieve swallowing-induced pain in patients receiving radiotherapy for nasopharyngeal carcinoma. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Doxepin solution (Doxepin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Swallowing-induced Pain | NA | Status: RECRUITING